Table 2. Echocardiographic characteristics and flow-mediated dilatation in csf patients.
| Clinical parameters | CSF (n = 33) | Controls (n = 48) | p-value |
| LVEDD (mm) | 48 (32–63) | 47 (39–69) | 0.755 |
| LVESD (mm) | 31 (23–48) | 28 (20–60) | 0.019 |
| LVEF (%) | 59 (27–76) | 64 (28–76) | 0.003 |
| LA (mm) | 38 (27–49) | 36 (26–56) | 0.059 |
| E wave (cm/s) | 66.3 ± 16.5 | 72.3 ± 17.5 | 0.127 |
| IVRT (ms) | 101.7 ± 22.7 | 96.9 ± 16.8 | 0.277 |
| E/A ratio | 1.06 (0.59–2.49) | 1.12 (0.61–2.86) | 0.973 |
| E/E′ ratio | 7 (3.8–15.4) | 8 (3.6–19.17) | 0.097 |
| Peak S (cm/s) | 8 (5–11) | 8 (6–13) | 0.077 |
| FMD (%) | 4.9 ± 6.6 | 7.9 ± 5.6 | 0.029 |
CSF, coronary slow flow; LVDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVEF, left ventricular ejection fraction; LA, left atrium; IVRT, isovolumetric relaxation time, FMD, flowmediated dilatation.